{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:43:40Z","timestamp":1789587820313,"version":"build-2803163510"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0212035","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T13:34:57Z","timestamp":1550151297000},"page":"e0212035","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Health system barriers to implementation of TB preventive strategies in South African primary care facilities"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8621-7718","authenticated-orcid":true,"given":"Eva","family":"Van Ginderdeuren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Hanrahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8184-3701","authenticated-orcid":true,"given":"Lillian","family":"Mutunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Van Rie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"key":"ref1","article-title":"Global tuberculosis report","year":"2016"},{"issue":"9777","key":"ref2","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","article-title":"6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"T Samandari","year":"2011","journal-title":"The Lancet"},{"issue":"9944","key":"ref3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0140-6736(14)60162-8","article-title":"Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial","volume":"384","author":"MX Rangaka","year":"2014","journal-title":"The Lancet"},{"key":"ref4","year":"2015"},{"key":"ref5","year":"2015"},{"key":"ref6","year":"2016"},{"issue":"Suppl 5","key":"ref7","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/01.aids.0000391021.18284.12","article-title":"Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study","volume":"24","author":"R Lester","year":"2010","journal-title":"AIDS"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1186\/s12889-016-3525-8","article-title":"Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study","volume":"16","author":"G Teklay","year":"2016","journal-title":"BMC public health"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7196\/SAMJ.8290","article-title":"Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB control","volume":"104","author":"GJ Churchyard","year":"2014","journal-title":"South African medical journal"},{"key":"ref10","year":"2011"},{"key":"ref11","year":"2015"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: A new method for characterising and designing behaviour change interventions","volume":"6","author":"S Michie","year":"2011","journal-title":"Implementation Science"},{"key":"ref13","unstructured":"Statistics South Africa. Diepsloot. Pretoria: Statistics South Africa;2011. Available from: http:\/\/www.statssa.gov.za\/?page_id=4286&id=11294<\/ext-link> (Accessed 14 July 2018.)"},{"key":"ref14","year":"2006"},{"key":"ref15","unstructured":"New Jersey Medical School Global Tuberculosis Institute. Mantoux Tuberculin Skin Testing training guide\u2013appendix 8. New Jersey, New Jersey Medical School Global Tuberculosis Institute, 2007. Available from: http:\/\/globaltb.njms.rutgers.edu\/downloads\/products\/CompleteTrainingGuide.pdf<\/ext-link> (Accessed 14 July 2018.)"},{"key":"ref16","year":"2012"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"903","DOI":"10.5588\/ijtld.11.0722","article-title":"Survey of isoniazid preventive therapy in South Africa, 2011","volume":"16","author":"JC Chehab","year":"2012","journal-title":"The international journal of tuberculosis and lung disease"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1097\/QAI.0000000000000895","article-title":"Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings","volume":"71","author":"H Huerga","year":"2016","journal-title":"Journal of acquired immune deficiency syndromes"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/QAI.0b013e3181f9fb39","article-title":"Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies","volume":"56","author":"A Van Rie","year":"2011","journal-title":"Journal of acquired immune deficiency syndromes"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":"Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda","volume":"21","author":"D Moore","year":"2007","journal-title":"AIDS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1478-4491-7-23","article-title":"Training health care workers to promote HIV services for patients with tuberculosis in the Democratic Republic of Congo","volume":"7","author":"K Vanden Driessche","year":"2009","journal-title":"Human resources for health"},{"key":"ref22","unstructured":"Swindells S, Ramchandani R., Gupta A., Benson C., Leon-Cruz J., Omoz-Oarhe A., et al. One month of rifapentine\/isoniazid to prevent TB in people with HIV: Brief-TB\/A5279 [abstract]. Presented in 25th Annual Conference on Retroviruses and Opportunistic Infections;2018 March 4\u20137; Boston, MA. Abstract nr 37LB. Available from: http:\/\/www.croiconference.org\/sessions\/one-month-rifapentineisoniazid-prevent-tb-people-hiv-brief-tba5279<\/ext-link> (Accessed 14 July 2018.)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0212035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T23:46:19Z","timestamp":1588981579000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0212035"}},"subtitle":[],"editor":[{"given":"Amrita","family":"Daftary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0212035","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]}}}